PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
Abstract Despite increasing incidence, treatment for hepatoblastoma has not changed significantly over the past 20 years. Chemotherapeutic strategies continue to rely on cisplatin, as it remains the most active single agent against hepatoblastoma. However, chemoresistance remains a significant chall...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/651d99d3286c48f987b6b07498bbc8c8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|